LOUDON, Tenn. and SAN DIEGO, Cal. (PRWEB) February 12, 2013
Genomatica and DuPont Tate & Lyle Bio Products Company, LLC (DT&L) announced the first successful commercial- scale production of 1,4-Butanediol (BDO) using a bio-based manufacturing process. BDO is an intermediate chemical used in a wide variety of applications including athletic apparel, electronics and automotive applications. This campaign, which spanned five weeks in late 2012, produced more than five million pounds (over 2,000 metric tons) of BDO by direct fermentation using conventional sugars as feedstock. This marks the first time that BDO– with an existing worldwide market of billions of pounds per year – has been produced biologically on this scale and at this rate. This campaign was completed less than five years from when Genomatica first demonstrated the ability for a microorganism to produce BDO in 2008.
“This was a sizable commercial-scale production campaign,” said Christophe Schilling, Genomatica’s Chief Executive Officer. “Partnering with DuPont Tate & Lyle brought us biochemical process know-how at significant scale to make the leap from demonstration to commercial volumes. The success of this campaign is a significant milestone for our technology and for the biochemical industry.”
DuPont Tate & Lyle has been running its leading-edge biochemical plant in Tennessee since 2006, producing 1,3-propanediol (PDO) at commercial volumes. The collaboration with Genomatica utilized DuPont Tate & Lyle’s commercial-scale batch fermentation operation to feed the plant’s continuous downstream processing.
“Utilizing Genomatica’s developments, we demonstrated the flexibility of our bioprocessing capability,” said Todd Sutton, president, DuPont Tate & Lyle Bio Pro
Copyright©2012 Vocus, Inc.
All rights reserved